Uranium Energy Slumps 30% From Peak but Bullish Undercurrents Remain

Uranium Energy shares fell 30% from peak to €11.80, while uranium spot price remains near $86/lb. Investors eye June 16 earnings and July 13 Section 232 decision as potential catalysts.

Uranium Energy shares ended last week at €11.80, capping a bruising stretch that has knocked the stock 30% below its 52-week high of €16.89. The weekly loss clocked in at roughly 8.5%, and the equity has declined in seven of the past ten trading sessions since the pivot peak set on 11 May. Yet the sell-off is unfolding against a backdrop that looks anything but bearish for the underlying commodity.

The uranium spot price has barely budged, hovering near $86 per pound, while long-term contract deals struck in the first quarter locked in at $90 per pound — the highest level since 2008. That divergence between a retreating stock and a resilient uranium market is drawing attention to a pair of catalysts that could reshape the narrative in the weeks ahead.

Two Dates on the Calendar

Investors are circling 16 June, when management reports fiscal third-quarter results. The quarter prior saw the company sell 200,000 pounds of uranium at $101 each, a premium to the prevailing spot market. With $818 million in cash and zero debt on the balance sheet, the company is well positioned to ramp production. Executives have flagged higher sales volumes for the second half of the year, making the upcoming release an early test of that guidance.

A second milestone arrives on 13 July, when the US government is expected to deliver a status update on the Section 232 investigation into uranium imports. Washington now treats uranium as a strategic asset and is pushing to slash reliance on foreign supplies. Potential outcomes include tariffs or import quotas, which would effectively create a price floor for domestically produced uranium. Uranium Energy has been preparing for exactly this scenario, building unhedged inventories to roughly 1.45 million pounds as of late January.

Technical Support in Focus

The chart tells a mixed story. The stock closed Friday just below its 50-day moving average of €12.12 and barely above the 200-day line at €11.72. The long-term trend remains intact so long as that €11.72 level holds. A break below it would signal further weakness. The MACD has triggered a sell signal on a three-month basis, and the 30-day annualized volatility stands at 73.86%, underscoring the stock’s susceptibility to sharp swings. The RSI, however, sits at a neutral 53.9, suggesting the decline has not reached oversold territory.

Structural Demand Meets Tight Supply

Despite the near-term technical damage, the fundamental case for uranium remains intact. New mine supply is coming online only slowly, while electricity demand is surging. Large technology companies are increasingly turning to nuclear power to run their data centres. Meta has signed agreements for up to 6.6 gigawatts of capacity by 2035, and Microsoft has secured more than 800 megawatts. The US Department of Energy is also committing $2.7 billion over the next decade to expand domestic enrichment capacity.

Analysts remain broadly constructive. The consensus twelve-month price target sits at $18.95, with Roth MKM maintaining a buy rating and BMO Capital taking a more cautious stance. For now, the share price is testing a critical support zone. A recovery back above €12.12 would calm near-term nerves, but the real test comes mid-June, when the quarterly numbers either validate the ramp-up story or give the bears more ammunition.